You searched for "drug"

253 results found

Hearing rehabilitation after vestibular schwannoma surgery

Hearing rehabilitation is a key focus of the management of patients with vestibular schwannoma. But how do we rehabilitate hearing when the cochlear nerve has been damaged by tumour, irradiation, or resective surgery? Mathieu Trudel, Scott Rutherford and Simon Lloyd...

Multi-channel cochlear implants: past, present and future

Forty years since the first multi-channel devices were implanted, who better than Ingeborg Hochmair, who has been a key figure throughout their evolution, to offer her thoughts on the past, present and future of multi-channel cochlear implants? Read on for...

BLA Position Statement - Interview with Mark Watson

Author and interviewer: Stefan Linton, ENT Registrar, Manchester Royal Infirmary. We caught up with Mark Watson, President of the British Laryngology Association, to find out his thoughts on the BLA’s position statement on the use of Gardasil vaccination in the...

Making audiology work during COVID-19 and beyond

‘New normal’ is another phrase that has become synonymous with this pandemic. In this article, consideration for ‘low-touch’ and ‘no touch’ audiological pathways are described for adoption as the ‘new normal’ for hearing healthcare. The COVID-19 crisis has ushered in...

Migraine related vertigo

Migraine is one of the commonest conditions an otologist will have to manage with up to half of migraineurs displaying vestibular symptoms. David Selvadurai provides an overview and management plan for this increasingly well recognised disorder. Migraine is a common...

The integration of targeted therapy and surgery in advanced thyroid cancer clinical trials

One of the headline speakers, Mark Zafereo, will be talking at IFOS about thyroid cancer. We hear from his team about some of the areas they will be discussing. Locally advanced thyroid cancer generally refers to patients who have significant...

Unanswered questions in adult ototoxicity associated with platinum-based chemotherapy

Do the potential side-effects on hearing and tinnitus need to be a ‘necessary evil’ of platinum-based chemotherapy? How strong is our evidence base when offering advice to patients and fellow clinicians? David Baguley and his team from the University of...

Genetic research on hereditary hearing loss and clinical application in the Chinese population

Congenital deafness in China affects more people than the entire population of Australia. Prof Wang give us a comprehensive insight into one of the main congenital disabilities in China, looking into the causes of deafness and the benefits of genetic...

Temporal bone trauma

Introduction Temporal bone injuries represent one of the more complex management problems presenting to the otolaryngologist. This is largely due to difficulties in assessment and the frequent delays in referral, often as a result of other injuries demanding more immediate...

Congenital CMV: investigations and management in the audiology setting

Congenital cytomegalovirus (cCMV) is the only cause of congenital sensorineural hearing loss (SNHL) for which there is a medical treatment available to prevent further hearing loss. Dr Simone Walter discusses cCMV infection, cCMV-related hearing loss, and how to facilitate their...

KUDUwave™ Boothless Audiometer

The KUDUwaveTM was designed to replace the need for a sound booth and enable truly portable audiometry in almost any environment. ENT & Audiology News’ own Gareth Smith, Priya Carling and Alex Griffiths Brown met in London to put the...

What’s hidden in hidden hearing loss?

In order to truly understand the many key aspects of acquired sensorineural hearing loss, the role of cochlear synaptopathy or ‘hidden hearing loss’ must be considered. Dan Guo and Sharon Kujawa review and summarise what we know to date, including...